Showing results (331-340 of 441) with videos related to

Sort By:
Pageof 45
Joint Commission Journal on Quality and Patient Safety|May 16, 2018
1,300 Days and Counting: A Risk Model Approach to Preventing Retained Foreign Objects (RFOs)Erika G Duggan, Jimmy Fernandez, Mary May Saulan, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 9, 2021
Bisphenol S and Bisphenol F Are Less Disruptive to Cardiac Electrophysiology, as Compared With Bisphenol ATomas M Prudencio, Luther M Swift, Devon Guerrelli, et al.
Journal of Substance Abuse Treatment|March 26, 2015
Contingent vouchers and motivational interviewing for cigarette smokers in residential substance abuse treatmentDamaris J Rohsenow, Jennifer W Tidey, Rosemarie A Martin, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 22, 2024
Predictors of syrinx presentation and outcomes in pediatric Chiari malformation type I: a single institution experience of 218 consecutive syrinx patientsEric Y Montgomery, James P Caruso, Angela V Price, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 28, 2022
A Simple and Reproducible In Vivo Rabbit Phonation Model for Glottic InsufficiencyWilliam M Swift, Ian T Churnin, Osama A Hamdi, et al.
Sleep|January 11, 2024
Altered sleep architecture following consecutive nights of presleep alcoholKatie S McCullar, David H Barker, John E McGeary, et al.
Nature Communications|May 15, 2024
Sustained bacterial N2O reduction at acidic pHGuang He, Gao Chen, Yongchao Xie, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 6, 2017
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Data in Brief|December 8, 2017
Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parametersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Addiction Biology|June 4, 2015
Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trialGeorge A Kenna, Carolina L Haass-Koffler, William H Zywiak, et al.
Pageof 45